When assessing a female client who has been taking an antipsychotic medication for the past year, the nurse observes that the client demonstrates involuntary foot tapping while both feet are flat on the floor. The nurse plans to report the observation to the healthcare provider. Which additional action should the nurse take?

Choice A reason: Involuntary foot tapping suggests tardive dyskinesia, a side effect of long-term antipsychotic use. Documenting on the Abnormal Involuntary Movement Scale (AIMS) quantifies and tracks this movement disorder, aiding provider evaluation, aligning with psychopharmacology monitoring protocols, making it the correct additional action.Choice B reason: Advising about medication tolerance is incorrect, as foot tapping indicates tardive dyskinesia, not tolerance. Tolerance implies reduced drug efficacy, not movement disorders. Documentation on AIMS is needed to assess this side effect, making this choice inappropriate for addressing the observed symptom.Choice C reason: Foot tapping is likely tardive dyskinesia, not an anxiety manifestation. Assisting with anxiety recognition misattributes the symptom, delaying proper evaluation. Documenting on AIMS ensures accurate assessment of antipsychotic side effects, making this incorrect for the nurse’s additional action in this scenario.Choice D reason: Seizure precautions are unwarranted, as foot tapping suggests tardive dyskinesia, not seizures. Antipsychotics rarely cause seizures, and this movement is non-epileptic. Documenting on AIMS is the appropriate action to evaluate this side effect, making seizure precautions incorrect and unnecessary.